Literature DB >> 7564083

Oxidation of low density lipoproteins from patients with renal failure or renal transplants.

W H Sutherland1, R J Walker, M J Ball, S A Stapley, M C Robertson.   

Abstract

Peroxidation of low density lipoproteins (LDL) may be involved in the development of atherosclerosis which is prevalent in patients with chronic renal failure and renal transplant recipients. We determined the copper ion catalyzed oxidation in vitro, vitamin E content, and chemical and fatty acid composition of LDL isolated from 38 patients with renal disease and 15 healthy subjects. Also the acute effect of hemodialysis treatment on LDL oxidation variables was tested. The lag time in conjugated diene formation during oxidation was significantly (P = 0.011) shorter in LDL from renal transplant recipients (66 min, N = 18) mainly due to significantly (P < 0.05) shorter times in women (47 min, N = 7), compared with healthy subjects (83 min, N = 15), patients on hemodialysis (91 min, N = 13) and patients treated by continuous ambulatory peritoneal dialysis (CAPD) (82 min, N = 7). The maximum rate and the extent of LDL oxidation were significantly (P < 0.01) lower in all patients with renal disease compared with healthy subjects. The triglyceride content of LDL was significantly (P < 0.001) higher in women with kidney grafts (7.3%) compared with levels in the corresponding men (5.3%) and healthy women (5.0%), and was correlated significantly with the lag time in LDL oxidation in renal transplant recipients (Spearmans r = -0.502, P = 0.034). The percentage oleic acid in LDL was significantly higher (P = 0.002) and the percentage linoleic acid was significantly lower (P = 0.046) in patients with renal disease, and may largely account for their lower rates and extent of LDL oxidation. Levels of the LDL oxidation variables and organic lipid peroxide content of LDL were not significantly different before and after hemodialysis and 24 hours later. These results suggest that LDL from women with renal transplants may be abnormally susceptible to oxidation possibly due to increased triglyceride content.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7564083     DOI: 10.1038/ki.1995.288

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  8 in total

1.  Immunological evidence for hypochlorite-modified proteins in human kidney.

Authors:  E Malle; C Woenckhaus; G Waeg; H Esterbauer; E F Gröne; H J Gröne
Journal:  Am J Pathol       Date:  1997-02       Impact factor: 4.307

2.  Lipid Profile In Transplant Patients: A Clinical Study.

Authors:  K V Baliga; P K Sharma; M S Prakash; M Mostafi
Journal:  Med J Armed Forces India       Date:  2011-07-21

Review 3.  Post-transplant dyslipidemia: Mechanisms, diagnosis and management.

Authors:  Arnav Agarwal; G V Ramesh Prasad
Journal:  World J Transplant       Date:  2016-03-24

4.  Effect of hemodialysis and peritoneal dialysis on redox status in chronic renal failure patients: a comparative study.

Authors:  Khedidja Mekki; Warda Taleb; Nassima Bouzidi; Abbou Kaddous; Malika Bouchenak
Journal:  Lipids Health Dis       Date:  2010-09-03       Impact factor: 3.876

Review 5.  Dyslipidemia in Transplant Patients: Which Therapy?

Authors:  Gabriella Iannuzzo; Gianluigi Cuomo; Anna Di Lorenzo; Maria Tripaldella; Vania Mallardo; Paola Iaccarino Idelson; Caterina Sagnelli; Antonello Sica; Massimiliano Creta; Javier Baltar; Felice Crocetto; Alessandro Bresciani; Marco Gentile; Armando Calogero; Francesco Giallauria
Journal:  J Clin Med       Date:  2022-07-14       Impact factor: 4.964

6.  Comparison of markers of oxidative stress, inflammation and arterial stiffness between incident hemodialysis and peritoneal dialysis patients--an observational study.

Authors:  Robert G Fassett; Ritza Driver; Helen Healy; Dwarakanathan Ranganathan; Sharad Ratanjee; Iain K Robertson; Dominic P Geraghty; James E Sharman; Jeff S Coombes
Journal:  BMC Nephrol       Date:  2009-03-12       Impact factor: 2.388

7.  Astaxanthin vs placebo on arterial stiffness, oxidative stress and inflammation in renal transplant patients (Xanthin): a randomised controlled trial.

Authors:  Robert G Fassett; Helen Healy; Ritza Driver; Iain K Robertson; Dominic P Geraghty; James E Sharman; Jeff S Coombes
Journal:  BMC Nephrol       Date:  2008-12-18       Impact factor: 2.388

8.  Status of antioxidant and homocysteine-lowering vitamins related to cardiovascular diseases in hemodialysis patients.

Authors:  Akram Kooshki; Mitra Eftekhari Yazdi; Manidgeh Yousefi Moghaddam; Roya Akbarzadeh
Journal:  Electron Physician       Date:  2017-07-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.